DXCM vs INDP · P/E 63, rev $2.50B vs $7.4M cap
DexCom Inc (DXCM) versus Indaptus Therapeutics Inc (INDP) — a side-by-side from cached financials, not a winner call.
DexCom Inc (DXCM) is a medical devices company listed on US.
Indaptus Therapeutics Inc (INDP) is a biotechnology company listed on US.
Latest reported DXCM revenue for 2026-06-30 was $2.50B. Net income was $448.6M. DXCM currently screens at market cap $32.84B and trailing P/E 62.5.
INDP does not have a complete income-statement cache yet.
DXCM currently screens at market cap $32.84B and trailing P/E 62.5. INDP currently screens at market cap $7.4M.
Not investment advice. Open the DXCM and INDP stock pages for the full models.
Not investment advice.